Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of 24 weeks of treatment with BIIL 284
BS compared with placebo on pulmonary function and incidence of pulmonary exacerbation in
adult and pediatric cystic fibrosis patients.